Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
LG H & H Co. Ltd. is managing 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are handled by 2 distinct examiners, indicating that each matter is being reviewed by a unique individual. This distribution ensures that the current filings are subject to different perspectives within the patent office. Such a spread can be beneficial for exploring various aspects of the company's pharmaceutical and biotechnological innovations.
GAREN GOTFREDSON is the busiest examiner for the portfolio, with 1 pending office action. The actions are also divided between distinct art units. For the company, this requires coordinating with different examiners in separate environments to advance the 2 pending office actions currently under review. This decentralized approach requires a tailored strategy for each case to address the specific prior art and patentability concerns of the assigned examiners in the Biotechnology & Pharmaceuticals sector.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| §103 only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GOTFREDSON, GAREN | 1 | 39.9% | +28.1% |
| WILLIAMS, EMMALEE RAE | 1 | 0.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18781747 | NOVEL LACTOBACILLUS SAKEI STRAIN AND USE THEREOF | WILLIAMS, EMMALEE RAE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18934727 | COMPOSITION FOR TOOTH WHITENING OR IMPROVING DENTIN HYPERSENSITIVITY COMPRISING POLYPHOSPHATE | GOTFREDSON, GAREN | — |
| Art Unit | Apps |
|---|---|
| 1619 | 1 |
| 1653 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18934727 | COMPOSITION FOR TOOTH WHITENING OR IMPROVING DENTIN HYPERSENSITIVITY COMPRISING POLYPHOSPHATE | GOTFREDSON, GAREN | 1619 | §103 | Non-Final OA | — | Pending | Nov 01, 2024 |
| 18781747 | NOVEL LACTOBACILLUS SAKEI STRAIN AND USE THEREOF | WILLIAMS, EMMALEE RAE | 1653 | §101§102§103§112 | Non-Final OA | — | Pending | Jul 23, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialLG H & H Co. Ltd. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Garen Gotfredson has the most, with 1 of LG H & H Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
